Mixed Results for Therapeutic Candidates for Platinum-Resistant Ovarian Cancer

[ad_1]

(MedPage Today) — Promising therapies for platinum-resistant ovarian cancer produced mixed results in separate trials.
The AKT inhibitor afuresertib failed to improve progression-free survival (PFS) when added to paclitaxel for patients with…

[ad_2]

Source link : https://www.medpagetoday.com/meetingcoverage/sgo/114677

Author :

Publish date : 2025-03-16 20:04:00

Copyright for syndicated content belongs to the linked Source.